Price $5.79 |
Market Cap
435.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
10.08
|
P/S
3.63
|
Dividend %
-
|
|
P/CF
76.1
|
P/FCF
-
|
Op. Cash Flow
-128.6K
|
FCF
-3.0
|
|
Op. Margin
-119.60%
|
Net Margin
-125.40%
|
ROE
-165.00%
|
ROI
-56.00%
|
|
ROA
-40.00%
|
EPS Growth
-35.10%
|
Current Ratio
4.9
|
Debt/Equity
494.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $7.23 | - | - | 9.93B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $1.65 | - | - | 28M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $1.10 | - | - | 103.8M | Strong Buy |
| Orthofix Medical Inc (OFIX) | $19.89 | - | - | 587.7M | Strong Buy |
| Ligand Pharmaceuticals Inc (LGND) | $75.31 | - | - | 1.22B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
